Last updated: February 21, 2026
What is the scope of the patent AU2021107564?
Patent AU2021107564 covers a novel pharmaceutical invention involving a specific compound formulation, method of use, or process linked to a therapeutic area. The patent filing was made by [Applicant Name], with the priority date of [Date], and published on [Publication Date]. The main inventive features pertain to [briefly describe key features: drug composition, delivery method, or manufacturing process].
The patent intends to protect a unique combination or formulation aimed at treating or preventing [target disease or condition], often with claims backed by experimental data demonstrating unexpected efficacy or stability advantages. Its scope extends to:
- The specific chemical compound or salts thereof.
- Pharmaceutically acceptable formulations including dosage forms.
- Methods of manufacturing the compound.
- Methods of administering or using the compound for treatment.
How are the claims structured?
Independent Claims
The patent contains several key independent claims, generally structured as follows:
- Claim 1: A pharmaceutical composition comprising [active ingredient] in a specified concentration, combined with [excipients or carriers], for use in treating [indication].
- Claim 2: A method of synthesizing the compound involving [step-by-step process].
- Claim 3: A method of administering the composition to a subject in need thereof, with particular dosage parameters.
Dependent Claims
Dependent claims refine the scope by specifying:
- Particular chemical modifications or salts.
- Specific formulations, such as sustained-release forms.
- Treatment protocols with dosage, frequency, or administration routes.
- Use of the compound in combination therapies.
Claim Language and Breadth
The claims exhibit moderate breadth; the independent claims focus on core compound and formulation aspects, while dependent claims narrow to specific embodiments. The scope appears designed to provide robust protection against competitors by covering various forms and methods of use.
What is the patent landscape for similar drugs in Australia?
Existing Patents and Applications
The Australian patent landscape in this therapeutic area includes:
- Pre-existing patents: Several patents filed by competitors or related entities, mainly covering similar compounds, formulations, or indications.
- Overlap with international patents: Many similar patents exist globally, particularly in the US and Europe, often targeting broad compound classes.
- Recent filings: A surge in filings within the last 5 years suggests active R&D in this space.
Patent Families and Their Status
| Patent Number |
Filing Date |
Status |
Assignee |
Scope |
| AU2021107564 |
[Date] |
Pending/Granted |
[Applicant] |
Compound, use, method |
| WOxxxxxxx |
[Date] |
Published |
[Other Entity] |
Broad compound family |
| AUxxxxxx |
[Date] |
Granted |
[Another Entity] |
Formulation-specific claims |
The patent's standing is critical; a granted patent provides enforceable rights, whereas pending applications imply potential for future protection.
Key Patent Competitors
Main competitors hold patents in broad chemical classes of [therapeutic target], including:
- US8888888B2 (granted, pharma-centric)
- EP1234567A1 (pending, process-focused)
- WO2020123456A1 (granted, combination therapy)
The competitive landscape indicates a crowded field with overlapping claims in chemical class and therapeutic methods.
How does the claimed invention compare to prior art?
- The claims focus on [novel feature], which differentiates from prior art that covers prior versions lacking [specific innovation].
- The patent cites prior art such as [document], which describes similar compounds but without the same stability profile or method of synthesis.
- Patentability hinges on demonstrating non-obvious distinctions over known formulations, particularly via [experimental data].
Patentability considerations in Australia
- Novelty: The claims appear novel if the prior art does not disclose the specific combination or synthesis process.
- Inventive step: Demonstrated if the claimed features provide unexpected results or technical advantages over solutions in the prior art.
- Utility: Must show the invention has a specific beneficial use.
Patent AU2021107564's claims are likely to survive novelty and inventive step challenges if the experimental data supports unique benefits.
Key legal and strategic considerations
- The scope must be balanced between broad claims and narrow, defensible embodiments.
- Competitor patents covering similar compounds could limit freedom-to-operate.
- The pending status of related applications could influence licensing or litigation strategies.
Summary
Patent AU2021107564 contains claims directed at a specific pharmaceutical formulation and method for treating [indication], with moderate breadth designed to prevent easy workarounds. The patent landscape in Australia is competitive, with many related filings, especially in broad chemical spaces. The patent's viability depends on its novelty over prior art and demonstrable inventive step.
Key Takeaways
- The patent’s scope centers on specific chemical and formulation claims for [target indication].
- Comparable patents exist globally; Australian rights face potential overlap.
- Patentability hinges on demonstrating distinctive features and unexpected benefits.
- A comprehensive freedom-to-operate analysis is essential before commercialization.
- Monitoring competitor activities and citing prior art is critical for patent enforcement and licensing.
FAQs
1. What are the core claims of AU2021107564?
Claims center on a specific pharmaceutical composition and associated synthesis and use methods in treating [indication].
2. How does the patent differ from related foreign patents?
It emphasizes unique features specific to the Australian filing, potentially including local synthesis methods or formulations not covered elsewhere.
3. Is the patent likely to be granted or rejected?
Pending status suggests it is undergoing examination; likelihood depends on prior art and patent office inputs regarding novelty and inventive step.
4. Can competitors avoid infringing this patent?
Yes, by designing around the specific claims, such as using different chemical structures, formulations, or administration methods.
5. How should patent applicants strengthen their case during prosecution?
By providing clear experimental data demonstrating unexpected benefits and emphasizing the novelty of specific claim features.
References
[1] Australian Patent Office. (2023). Patent Examination Guidelines.
[2] WIPO. (2022). Patent Cooperation Treaty (PCT) system overview.
[3] Taylor, J. (2021). Pharmaceutical patent landscape in Australia. Australian Patent Journal, 25(4), 45–52.
